Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Feb;62(2):378-82.
doi: 10.1002/art.27194.

Could accelerated aging explain the excess mortality in patients with seropositive rheumatoid arthritis?

Cynthia S Crowson  1 , Kimberly P Liang, Terry M Therneau, Hilal Maradit Kremers, Sherine E Gabriel
Affiliations

Could accelerated aging explain the excess mortality in patients with seropositive rheumatoid arthritis?

Cynthia S Crowson et al. Arthritis Rheum. 2010 Feb.

Abstract

Objective: To determine whether the mortality pattern in patients with seropositive rheumatoid arthritis (RA) is consistent with the concept of accelerated aging, by comparing the observed mortality rates in patients with RA with the age-accelerated mortality rates from the general population.

Methods: A population-based inception cohort of patients with seropositive RA (according to the American College of Rheumatology 1987 criteria) was assembled and followed up for vital status until July 1, 2008. The expected mortality rate was obtained by applying the death rates from the general population to the age, sex, and calendar year distribution of the RA population. The observed mortality was estimated using Kaplan-Meier methods. Acceleration factors for the expected mortality were estimated in accelerated failure time models.

Results: A total of 755 patients with seropositive RA (mean age 55.6 years, 69% women) were followed up for a mean of 12.5 years, during which 315 patients died. The expected median survival was age 82.4 years, whereas the median survival of the RA patients was age 76.7 years. Results of statistical modeling suggested that, in terms of mortality rates, patients with RA were effectively 2 years older than actual age at RA incidence, and thereafter the patients underwent 11.4 effective years of aging for each 10 years of calendar time.

Conclusion: The overall observed mortality experience of patients with seropositive RA is consistent with the hypothesis of accelerated aging. The causes of accelerated aging in RA deserve further investigation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Overall survival of 755 seropositive RA patients vs. age. Observed, expected and fitted (using the full model) curves are shown.
See this image and copyright information in PMC

References

    1. Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 2008;58(1):15–25. - PubMed
    1. Gonzalez A, Icen M, Kremers HM, Crowson CS, Davis JM, 3rd, Therneau TM, et al. Mortality trends in rheumatoid arthritis: the role of rheumatoid factor. [see comment] Journal of Rheumatology. 2008;35(6):1009–1014. - PMC - PubMed
    1. Gabriel SE, Crowson CS, Maradit Kremers H, Doran MF, Turesson C, O'Fallon WM, et al. Survival in Rheumatoid Arthritis: A Population-Based Analysis of Trends over 40 Years. Arthritis & Rheumatism. 2003;48(1):54–58. - PubMed
    1. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis & Rheumatism. 1988;31(3):315–324. - PubMed
    1. Melton L. History of the Rochester Epidemiology Project. Mayo Clinic Proceedings. 1996;71:266–274. - PubMed

Publication types